Analysis for MMM
- 📈 Growth — 8/30
- 💰 Profitability — 14/20
- 🏦 Financial Health — 12/20
- 💵 Valuation — 12/20
- ⚠️ Risk — 7/10
Summary:
📈 Growth & Financial Trajectory
Over the 8 quarters, Revenues hovered around the low-to-mid $6B range, ending at about $6.03B in 2026 Q1 after starting near $6.26B in 2024 Q2. Net Income fell from roughly $1.15B to about $0.66B, with notable volatility (peak in 2024 Q3, troughs in 2024 Q4 and 2025 Q4). The trajectory is largely flat-to-down, with mid-year upticks but an overall earnings erosion despite stable top-line results.
💰 Margins & Cash Flow
Gross margins remained in the ~40%+ range most quarters, with a dip to ~31.6% in 2025 Q4 before rebounding. This reflects mix shifts and cost dynamics across periods. Operating cash flow was positive in several quarters (e.g., 2026 Q1 ~ 574M), but quarterly cash flow swung due to investing/financing activity, yielding mixed net cash outcomes and notable cash flow volatility.
🛡️ Balance Sheet & Liquidity
Assets consistently around the mid-to-high $30B range; Liabilities near $32–33B with equity around $3–4B, implying modest equity cushion. Current assets exceed current liabilities, giving a liquidity hint (current ratio around ~1.5). Long-term debt sits ~$12–13B, and operating cash flow has supported liquidity in many quarters despite negative financing activity in several periods.
⚠️ Key Drivers & Risks
- Drivers: ongoing manufacturing activity and efficiency/cost-optimization programs sustaining product demand across sectors.
- Risks: cyclicality in industrial demand and margin compression pressures; cash-flow volatility from financing/investing activities and potential sensitivity to macro health.}